Скачать 218.92 Kb.
National Vaccine Advisory Committee (NVAC)
October 5-6, 2004 meeting
Several working groups provided reports and recommendations, three of which were accepted by vote of the full Committee.
The Vaccine Safety & Communication Subcommittee received a presentation by Dr. Melinda Wharton, NIP, about the IOM review of the NIP Vaccine Safety Datalink data sharing program. The IOM’s final reports are expected to be released in November 2004 (reviewing and presenting recommendations on the program) and in February 2005 (reviewing and presenting recommendations for the handling of preliminary data obtained by Datalink). While the Immunization Coverage & Future Vaccines Subcommittees held a joint meeting to begin the planning of a National Stakeholder Meeting on Strategies to Increase the Uptake of New Vaccines for Adolescents, currently proposed to be held in June 2005. The goals of such a meeting would be to identify the strengths and weaknesses of key implementation strategies and issues; identify approaches that will effectively and efficiently increase the proportion of adolescents who receive vaccines; develop plans to implement these approaches; and to identify research initiatives in support of the successful introduction of these new vaccines and to accelerate the development of vaccines in the ‘pipeline.’
Other presentations of interest included the following: a review of the 2004-2005 Influenza Season (Drs. Steven Cochi, Eddie Wilder, and Alan Janssen, NIP), National Children’s Health Study (Dr. Peter Scheidt, NIH), an update of the READII program (Tamara Kicera, NIP), and an overview of project Bioshield (Monique Mansoura, OPHEP).
Agency and committee updates were presented by: NIP/ACIP (Dr. Steve Cochi - CDC), ACCV/DVIC (Dr. Geoff Evans - HRSA), FDA/VRBPAC (Dr. Gary Overturf – University of Mexico, VRBPAC Chair and NVAC liaison), NIH (Dr. George Curlin – NIAID).
Committee Members in Attendance
Dr. Charles M. Helms—Chair
Dr. Ann Margaret Arvin
Dr. Fernando A. Guerra
Dr. Alan Richard Hinman
Dr. David Johnson
Dr. Jerome O. Klein
Mary Beth Koslap-Petraco
Dr. Richard Raymond
Dr. William Schaffner
Dr. Patricia N. Whitley-Williams
Dr. Adele Young
Dr. Bruce Gellin, NVPO
Dr. Gary D. Overturf, VRBPAC/FDA
Dr. Myron Levin, ACIP/CDC
Dr. Steve Cochi, Acting Director, NIP/CDC
Dr. George Curlin, Special Advisor, NIH
Col. Renata J. M. Engler, Chief, Allergy/Immunology Dept., Walter Reed, DoD
Dr. Geoffrey Evans, Medical Director, VICP/HRSA
Dr. James Randolph Farris, Regional Administrator, Region VI, CMS
Emily Marcus Levine, Senior Attorney, OGC/DHHS
Committee Members Absent
Dr. Gary Freed
Dr. Steven Black, Liaison, AAHP and Director, Vaccine Study Center, Kaiser Permanente
Jackie Noyes, Liaison, Advisory Commission on Childhood Vaccines
Dr. Norman Baylor, Microbiologist, CBER/FDA
Neal Brandes, USAID
Dr. Cristina Beato, Acting Assistant Secretary of Health, DHHS
Alan P. Janssen, Office of Health Communication, NIP/CDC
Ms. Tamara J. Kicera, NIP/CDC
Dr. Monique K. Mansoura, Office of Research and Development Coordination, DHHS
Dr. Benjamin Schwartz, NVPO
Dr. Peter Scheidt, National Children’s Health Study, NIH
Dr. Eddie Wilder, Public Health Advisor, Immunization Services Division, NIP/CDC
Dr. Donald Williamson, NVAC Working Group on Public Health Options for Implementing Vaccine Recommendations
Day 1 – October 5, 2004
Welcome from the National Vaccine Advisory Committee Chair – Dr. Charles Helms
Dr. Helms thanked NVAC members and noted that Dr. Bruce Gellin was “putting out a fire” and would join them when he could. He suggested they begin the meeting to stay on schedule. Dr. Helms then introduced himself and asked the attendees to introduce themselves.
Dr. Helms gave a brief report to update the committee. He brought members’ attention to the solicitation for nominations for NVAC. He noted that committees such as NVAC are ongoing because of the participation of expert individuals whose presence on such committees can increase productivity and improve advice offered to the government.
Dr. Helms noted that they have been very busy in response to Dr. Beato’s request for a preliminary report from the Influenza Working Group, as well as many other things that would be reported on during the meeting. The DHHS Draft Pandemic Influenza Preparedness and Response Plan is now publicly available and comments are being solicited. In addition, Dr. Alan Hinman, who chairs the Working Group on Pandemic Influenza, created to provide NVAC comments on the plan, will be presenting some of these comments for deliberation. The Influenza Working Group will give a presentation on its preliminary report and Dr. Hinman would also be reporting on the follow-up on the IOM report on vaccine financing. Ruth Katz will also give an important presentation on a recent meeting held by the Working Group on Public Participation, which she chairs.
Dr. Helms noted that there would be a special joint meeting of the Immunization Coverage and Future Vaccines Subcommittees to discuss a possible stakeholder meeting on adolescent immunization. Upcoming Influenza Season
|Food and drug administration national institutes of health advisory Committee on: transmissible spongiform||Veterinary medicine advisory committee|
|Ranch hand advisory committee||Medical Devices Advisory Committee|
|Advisory committee on immunization practices||Wildlife Diversity Policy Advisory Committee|
|External Advisory Committee on Cities and Communities||Peer reviewed by the Arizona Department of Commerce Economic Research Advisory Committee|
|Advisory Committee, Cuyahoga Valley School-to-Career Consortium, Broadview Heights, Ohio 1996-2002||Jane D. Siegel, md; Emily Rhinehart, rn mph cic; Marguerite Jackson, PhD; Linda Chiarello, rn ms; the Healthcare Infection Control Practices Advisory Committee|